Literature DB >> 7966189

A comparison of the clinical and cytogenetic findings in nine patients with a ring (X) cell line and 16 45,X patients.

A L Collins1, A E Cockwell, P A Jacobs, N R Dennis.   

Abstract

In this study, the clinical, IQ, and cytogenetic findings in nine Turner's syndrome patients with a ring (X) cell line are compared with those in 16 patients in whom only a 45,X cell line could be found. The ring (X) patients lacked many of the "classic" Turner's syndrome features and the majority were not karyotyped until after the age of 11, usually because of pubertal failure. They also showed a reduction in IQ of 11 points compared with the 45,X group. Some ring (X) patients show characteristic facial features including a broad nose with anteverted nostrils, prominent philtrum, long palpebral fissures, and a wide mouth with a thin upper lip. Neither the physical features nor the IQ are related to the parental origin of the chromosome error. In the majority of cases the ring (X) chromosome was late replicating but XIST activity is being studied further.

Entities:  

Mesh:

Year:  1994        PMID: 7966189      PMCID: PMC1049974          DOI: 10.1136/jmg.31.7.528

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  18 in total

1.  A cytogenetic and molecular reappraisal of a series of patients with Turner's syndrome.

Authors:  P A Jacobs; P R Betts; A E Cockwell; J A Crolla; M J Mackenzie; D O Robinson; S A Youings
Journal:  Ann Hum Genet       Date:  1990-07       Impact factor: 1.670

2.  Chromosomal and clinical findings in 110 females with Turner syndrome.

Authors:  C G Palmer; A Reichmann
Journal:  Hum Genet       Date:  1976-12-29       Impact factor: 4.132

3.  High incidence of mental retardation in Turner syndrome patients with ring chromosome X formation.

Authors:  J P Fryns; A Kleczkowska; H Van Den Berghe
Journal:  Genet Couns       Date:  1990

4.  45X/46X,r(X) with syndactyly and severe mental retardation.

Authors:  T Kushnick; T G Irons; J E Wiley; E A Gettig; K W Rao; S Bowyer
Journal:  Am J Med Genet       Date:  1987-11

Review 5.  Kabuki make-up (Niikawa-Kuroki) syndrome: a study of 62 patients.

Authors:  N Niikawa; Y Kuroki; T Kajii; N Matsuura; S Ishikiriyama; H Tonoki; N Ishikawa; Y Yamada; M Fujita; H Umemoto
Journal:  Am J Med Genet       Date:  1988-11

6.  Intellegence among persons with Turner's syndrome.

Authors:  D C Garron
Journal:  Behav Genet       Date:  1977-03       Impact factor: 2.805

7.  Cognitive development of unselected girls with complete and partial X monosomy.

Authors:  B Bender; M Puck; J Salbenblatt; A Robinson
Journal:  Pediatrics       Date:  1984-02       Impact factor: 7.124

8.  Turner syndrome patients with a ring X chromosome.

Authors:  G Berkovitz; J Stamberg; L P Plotnick; R Lanes
Journal:  Clin Genet       Date:  1983-06       Impact factor: 4.438

9.  Fetal cystic hygroma. Cause and natural history.

Authors:  F A Chervenak; G Isaacson; K J Blakemore; W R Breg; J C Hobbins; R L Berkowitz; M Tortora; K Mayden; M J Mahoney
Journal:  N Engl J Med       Date:  1983-10-06       Impact factor: 91.245

10.  A gene from the region of the human X inactivation centre is expressed exclusively from the inactive X chromosome.

Authors:  C J Brown; A Ballabio; J L Rupert; R G Lafreniere; M Grompe; R Tonlorenzi; H F Willard
Journal:  Nature       Date:  1991-01-03       Impact factor: 49.962

View more
  3 in total

Review 1.  Optimising management in Turner syndrome: from infancy to adult transfer.

Authors:  M D C Donaldson; E J Gault; K W Tan; D B Dunger
Journal:  Arch Dis Child       Date:  2006-06       Impact factor: 3.791

2.  Update and Review: Supernumerary Marker Chromosomes.

Authors:  S Ungerleider
Journal:  J Genet Couns       Date:  2000-08       Impact factor: 2.537

3.  Common variable immunodeficiency with CD4+ T lymphocytopenia and overproduction of soluble IL-2 receptor associated with Turner's syndrome and dorsal kyphoscoliosis.

Authors:  R A al-Attas; A H Rahi
Journal:  J Clin Pathol       Date:  1997-10       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.